These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
65 related articles for article (PubMed ID: 2505399)
1. Prenatal alpha-difluoromethylornithine treatment: effects on postnatal renal growth and function in the rat. Gray JA; Rehnberg BF; Rogers EH; Lau C; Slotkin TA; Kavlock RJ Teratology; 1989 Aug; 40(2):105-11. PubMed ID: 2505399 [TBL] [Abstract][Full Text] [Related]
2. Physiological consequences of early neonatal growth retardation: effects of alpha-difluoromethylornithine on renal growth and function in the rat. Gray JA; Kavlock RJ Teratology; 1991 Jan; 43(1):19-26. PubMed ID: 2006469 [TBL] [Abstract][Full Text] [Related]
3. Control of nucleic acid and protein synthesis in developing brain, kidney, and heart of the neonatal rat: effects of alpha-difluoromethylornithine, a specific, irreversible inhibitor of ornithine decarboxylase. Slotkin TA; Persons D; Slepetis RJ; Taylor D; Bartolome J Teratology; 1984 Oct; 30(2):211-24. PubMed ID: 6208628 [TBL] [Abstract][Full Text] [Related]
4. Fetal development in the rat following disruption of maternal renal function during pregnancy. Kavlock RJ; Logsdon T; Gray JA Teratology; 1993 Sep; 48(3):247-58. PubMed ID: 8248862 [TBL] [Abstract][Full Text] [Related]
5. Ornithine decarboxylase and polyamines in tissues of the neonatal rat: effects of alpha-difluoromethylornithine, a specific, irreversible inhibitor of ornithine decarboxylase. Slotkin TA; Seidler FJ; Trepanier PA; Whitmore WL; Lerea L; Barnes GA; Weigel SJ; Bartolome J J Pharmacol Exp Ther; 1982 Sep; 222(3):741-5. PubMed ID: 6809932 [TBL] [Abstract][Full Text] [Related]
6. Adverse effects of prenatal exposure to atrazine during a critical period of mammary gland growth. Rayner JL; Enoch RR; Fenton SE Toxicol Sci; 2005 Sep; 87(1):255-66. PubMed ID: 15933227 [TBL] [Abstract][Full Text] [Related]
7. Postnatal toxicity following prenatal reserpine exposure in rats: effects of dose and dosing schedule. Buelke-Sam J; Kimmel GL; Webb PJ; Slikker W; Newport GD; Nelson CJ; Kimmel CA Fundam Appl Toxicol; 1984 Dec; 4(6):983-91. PubMed ID: 6519379 [TBL] [Abstract][Full Text] [Related]
8. Early biochemical detection of adverse effects of a neurobehavioral teratogen: influence of prenatal methylmercury exposure on ornithine decarboxylase in brain and other tissues of fetal and neonatal rat. Slotkin TA; Pachman S; Kavlock RJ; Bartolome J Teratology; 1985 Oct; 32(2):195-202. PubMed ID: 4049277 [TBL] [Abstract][Full Text] [Related]
9. Effects of eflornithine hydrochloride (DFMO) on fetal development in rats and rabbits. O'Toole BA; Huffman KW; Gibson JP Teratology; 1989 Feb; 39(2):103-13. PubMed ID: 2494758 [TBL] [Abstract][Full Text] [Related]
10. Prenatal neuroleptic exposure and growth stunting in the rat: an in vivo and in vitro examination of sensitive periods and possible mechanisms. Holson RR; Webb PJ; Grafton TF; Hansen DK Teratology; 1994 Aug; 50(2):125-36. PubMed ID: 7801300 [TBL] [Abstract][Full Text] [Related]
11. Pre- and postnatal development studies of lasofoxifene, a selective estrogen receptor modulator (SERM), in Sprague-Dawley rats. Weisenburger WP; Hagler AR; Tassinari MS Birth Defects Res B Dev Reprod Toxicol; 2004 Jun; 71(3):171-84. PubMed ID: 15282738 [TBL] [Abstract][Full Text] [Related]
12. Spatial acquisition in the Morris water maze and hippocampal long-term potentiation in the adult guinea pig following brain growth spurt--prenatal ethanol exposure. Byrnes ML; Richardson DP; Brien JF; Reynolds JN; Dringenberg HC Neurotoxicol Teratol; 2004; 26(4):543-51. PubMed ID: 15203176 [TBL] [Abstract][Full Text] [Related]
13. NTP technical report on the toxicity studies of Dibutyl Phthalate (CAS No. 84-74-2) Administered in Feed to F344/N Rats and B6C3F1 Mice. Marsman D Toxic Rep Ser; 1995 Apr; 30():1-G5. PubMed ID: 12209194 [TBL] [Abstract][Full Text] [Related]
14. Fetal dexamethasone exposure accelerates development of renal function: relationship to dose, cell differentiation and growth inhibition. Slotkin TA; Seidler FJ; Kavlock RJ; Gray JA J Dev Physiol; 1992 Feb; 17(2):55-61. PubMed ID: 1500634 [TBL] [Abstract][Full Text] [Related]
15. Defining the susceptible period of developmental toxicity for the AT1-selective angiotensin II receptor antagonist losartan in rats. Spence SG; Allen HL; Cukierski MA; Manson JM; Robertson RT; Eydelloth RS Teratology; 1995 Jun; 51(6):367-82. PubMed ID: 7502237 [TBL] [Abstract][Full Text] [Related]
16. Impaired development of central and peripheral catecholamine neurotransmitter systems in preweanling rats treated with alpha-difluoromethylornithine, a specific irreversible inhibitor of ornithine decarboxylase. Slotkin TA; Grignolo A; Whitmore WL; Lerea L; Trepanier PA; Barnes GA; Weigel SJ; Seidler FJ; Bartolome J J Pharmacol Exp Ther; 1982 Sep; 222(3):746-51. PubMed ID: 6125588 [TBL] [Abstract][Full Text] [Related]
17. Dose-dependent effect of prenatal dexamethasone treatment on beta-adrenergic receptor coupling to ornithine decarboxylase and cyclic AMP. Bian XP; Seidler FJ; Bartolome J; Kavlock RJ; Bartolome M; Slotkin TA J Dev Physiol; 1990 Sep; 14(3):125-30. PubMed ID: 1966107 [TBL] [Abstract][Full Text] [Related]
18. Prenatal methamphetamine attenuates serotonin mediated renin secretion in male and female rat progeny: evidence for selective long-term dysfunction of serotonin pathways in brain. Cabrera TM; Levy AD; Li Q; van de Kar LD; Battaglia G Synapse; 1993 Nov; 15(3):198-208. PubMed ID: 8278897 [TBL] [Abstract][Full Text] [Related]
20. Effects of alpha-difluoromethylornithine on the growth of experimental Wilms' tumor and renal adenocarcinoma. Kingsnorth AN; McCann PP; Diekema KA; Ross JS; Malt RA Cancer Res; 1983 Sep; 43(9):4031-4. PubMed ID: 6307502 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]